Design, Synthesis, Molecular Dynamics, and In Vitro Evaluation of Isatin‐Based Quinazoline Derivatives as Potential Antidiabetic Agents
Chemistry & Biodiversity · 2026-09 · 23 (9)
DOI: 10.1002/cbdv.71694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 10.09.2026. Verfasst von Sahil Jaidka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Quinazolines, alpha-Amylases, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A series of substituted indolo[2,1‐b]quinazoline‐6,12‐diones (SJ1‐SJ8), which consist of already published derivatives (SJ1‐SJ5) and newly synthesized derivatives (SJ6‐SJ8), has been studied for their possible α‐amylase inhibition property as an antidiabetic lead compound. The synthesized derivatives have been identified by spectroscopy and analysis methods and tested for their in vitro α‐amylase inhibitory activity. The most potent inhibitory activity among the tested derivatives was showed by SJ2 (IC 50 = 18.49 ± 0.06 µM), similar to the reference drug acarbose (IC 50 = 16.26 ± 0.02 µM). The second‐best activity was observed for the newly identified derivative SJ8 (IC 50 = 19.67 ± 0.19 µM). Molecular docking and 100 ns molecular dynamics simulations supported favorable and stable interactions of SJ2 in the α‐amylase active site, while MM‐PBSA analysis showed favorable binding energetics. The electronic properties of SJ2 were also clarified by DFT and molecular electrostatic potential analyzes, and in silico ADMET profiling indicated promising predicted drug‐like and pharmacokinetic properties. To summarize, SJ2 is a promising lead for α‐amylase inhibition, which needs further optimization and biological validation. Future evaluation against α‐glucosidase and relevant in vivo models will be essential to determine the more general antidiabetic potential of this scaffold.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
- Department of Pharmaceutical Engineering and Technology, IIT BHU, Varanasi, India.
ORCID-Profile: Sahil Jaidka, Ankush Kumar, Christopher Basumatary, Thakur Gurjeet Singh, Rohit Bhatia
Zitieren
APA
Jaidka, S., Kumar, A., Basumatary, C., Singh, T. G., & Bhatia, R. (2026). Design, Synthesis, Molecular Dynamics, and In Vitro Evaluation of Isatin‐Based Quinazoline Derivatives as Potential Antidiabetic Agents. Chemistry & Biodiversity, 23(9). https://doi.org/10.1002/cbdv.71694
Vancouver
Jaidka S, Kumar A, Basumatary C, Singh TG, Bhatia R. Design, Synthesis, Molecular Dynamics, and In Vitro Evaluation of Isatin‐Based Quinazoline Derivatives as Potential Antidiabetic Agents. Chemistry & Biodiversity. 2026;23(9). doi:10.1002/cbdv.71694
BibTeX
@article{Jaidka2026,
author = {Jaidka, Sahil and Kumar, Ankush and Basumatary, Christopher and Singh, Thakur Gurjeet and Bhatia, Rohit},
title = {Design, Synthesis, Molecular Dynamics, and In Vitro Evaluation of Isatin‐Based Quinazoline Derivatives as Potential Antidiabetic Agents},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {9},
doi = {10.1002/cbdv.71694}
}
EUVIMED